We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Muscle Stimulator Treats Female Urinary Incontinence

By HospiMedica International staff writers
Posted on 19 Mar 2012
A novel muscle stimulator helps strengthen pelvic floor muscles for treatment of female urinary incontinence.

The InTone device is an electric stimulator with a pressure sensor that combines the benefits of gentle muscle stimulation with voice-guided instruction and visual biofeedback to strengthen the pelvic floor muscles and treat unwanted bladder leakage. More...
The device is made from phthalate free, latex free, medical grade silicone to ensure patient comfort, with a revolutionary patented design that helps arrive at a perfect fit by inflation, and does not need to be size-adjusted.

A physician customizes the settings for the InTone device and the patient is then shown how to use it at home; a sensor in the unit measures pressure to determine if the patient is doing the exercises properly, and a biofeedback unit uses voice-guided instruction to take the patient through the routine and report muscle isolation and strength. Each daily session takes about ten minutes, and data from each session is recorded. After two weeks, the physician analyzes the recorded data and adjusts the device based on the patient's progress, and the at-home treatment sessions continue.

Most patients should experience progress in a few weeks, and most patients should experience effective relief in 90 days. The InTone device is a product of InControl Medical (Brookfield, WI, USA), and has been approved by the US Food and Drug Administration (FDA).

“InTone is a true medical breakthrough, and welcome news for the millions of women who have incontinence issues,” said Herschel "Buzz" Peddicord, President and CEO of InControl Medical, and inventor of InTone. “With InTone, we believe we can effectively treat this condition in most cases.”

Related Links:
InControl Medical


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Premium Air-Mattress
MA-51
Spirometry & Oximetry Software
MIR Spiro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.